LVIS553 transcriptional regulator specifically recognizes novobiocin as an effector molecule.
Pagliai
Fernando A
FA
Department of Microbiology and Cell Science, Genetics Institute, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, Florida 32610-3610, USA.
Gardner
Christopher L
CL
Pande
Santosh G
SG
Lorca
Graciela L
GL
D000495:Allosteric Site; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D001412:Bacillus subtilis / Q000235:genetics; D002875:Chromosomes / Q000648:ultrastructure; D003850:Deoxyribonuclease I / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D029968:Escherichia coli Proteins / Q000235:genetics*; D005470:Fluorometry / Q000379:methods; D007700:Kinetics; D052196:Levilactobacillus brevis / Q000235:genetics* / Q000378:metabolism; D008024:Ligands; D008239:Lysine / Q000737:chemistry; D016297:Mutagenesis, Site-Directed; D009675:Novobiocin / Q000737:chemistry* / Q000494:pharmacology; D012097:Repressor Proteins / Q000235:genetics*; D014157:Transcription Factors / Q000737:chemistry* / Q000235:genetics; D014158:Transcription, Genetic
D000900:Anti-Bacterial Agents; D029968:Escherichia coli Proteins; D008024:Ligands; C080004:MarR protein, E coli; D012097:Repressor Proteins; D014157:Transcription Factors; D009675:Novobiocin; D003850:Deoxyribonuclease I; D008239:Lysine